Sophisticated science? Check. cuRNA, one of the first two spinoffs from Scripps Florida, is based on research by Scripps Florida’s Claes Wahlestedt, a Swede who thinks he has found a breakthrough in the so-called upregulation of RNA. The company already has filed 80 patents.
Quirky name? Check. cuRNA’s moniker combines cure and RNA, or ribonucleic acid, the molecules that make proteins.
Altruistic chief executive officer? Check. cuRNA is run and bankrolled by Joe Collard, a Delray Beach millionaire who made his money founding a tech company.
Florida Biotech: 2014 BioFlorida Life Sciences Annual Conference http://t.co/0AWLXyLA40 #biotech #biotechnology #florida
Florida Biotech: Contributed Tweets for @flabiotechnews are delivered by @RoundTeam https://t.co/KtkdD8pcOX
IScienceWriter: Thanks for the RTs this week! @sciencestream @flabiotechnews @cathcoste @arnui @EmmaPettengale via http://t.co/Gizn7dqbJc
Find us on Google+